Zusammenfassung
Der erste Schritt in der Therapie der Hodentumoren ist die inguinale Ablatio testis. Nur bei weit fortgeschrittener Erkrankung erfolgt initial die Chemotherapie und dann sekundär die ablatio testis. Nach fälschlich erfolgter skrotaler Ablatio testis, muß keine Korrekturoperation erfolgen. Die organerhaltende Teilresektion ist indiziert bei benignen Tumoren oder bei Solitärhoden. Nach organerhaltender Op eines Keimzelltumors sollte eine adjuvante Strahlentherapie des Resthodens erfolgen, um die obligatorische Keimzellneoplasie in situ zu eradizieren. Die Implantation einer Silikonhodenprothese sollte präoperativ angeboten werden. Die kontralaterale Hodenbiopsie dient der Früherkennung eines Zweittumors auf der Stufe der Keimzellneoplasie in situ, die sich bei 5–6 % der Fälle findet. Erhöhtes Risiko besteht bei Patienten unter 40 Jahren sowie bei Hodenatrophie. Diesen Patienten sollte die kontralaterale Doppelbiopsie empfohlen werden. Die Bereitstellung einer Fertilitätsreserve in Form einer Kryospermadeponierung sollte möglichst frühzeitig mit dem Patienten besprochen werden.
Literatur
Albers P, Dieckmann K-P (1998) Hodentumoren: Diagnostik und Therapie des Primärtumors. Onkologe 4:487–493
Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP, Nicolai N, Oldenburg J (2015) Guidelines on testicular cancer: 2015 update. Eur Urol 68:1054–1068
Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fossa SD (2011) Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953–2007). Int J Cancer 129(12):2867–2874
Angulo JC, González J, Rodríguez N, Hernández E, Núñez C, Rodríguez-Barbero JM, Santana A, López JI (2009) Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms). J Urol 182(5):2303–2310
Anheuser P, Kranz J, Will J, Dieckmann KP (2014) Complications associated with inguinal orchiectomy and scrotal orchiectomy.[Article in German]. Urologe A 53(5):676–682
Ashdown DA, Bodiwala D, Liu S (2004) Is high cord radical orchidectomy always necessary for testicular cancer? Ann R Coll Surg Engl 86:289–291
Azzopardi JG, Mostofi FK, Theiss EA (1961) Lesions of the testes observed in certain patients with widespread choriocarcinoma and related tumors. The significance and genesis of hematoxylin-staining bodies in the human testis. Am J Pathol 38:207–225
Bell D, Morash C, Dranitsaris G, Izawa J, Short T, Klotz LH, Fleshner N (2006) Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature. Can J Urol 13(3):30–36
Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Claßen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann KP, Fenner M, Fizazi K, Flechon A, Fossa SD, Germá Lluch JR, Gietema JA, Gillessen S, Giwercman A, Hartmann JT, Heidenreich A, Hentrich M, Honecker F, Horwich A, Huddart RA, Kliesch S, Kollmannsberger C, Krege S, Laguna MP, Looijenga LH, Lorch A, Lotz JP, Mayer F, Necchi A, Nicolai N, Nuver J, Oechsle K, Oldenburg J, Oosterhuis JW, Powles T, Rajpert-De Meyts E, Rick O, Rosti G, Salvioni R, Schrader M, Schweyer S, Sedlmayer F, Sohaib A, Souchon R, Tandstad T, Winter C, Wittekind C (2013) Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 24(4):878–888
Bodiwala D, Summerton DJ, Terry TR (2007) Testicular prostheses: development and modern usage. Ann R Coll Surg Engl 89:349–353
Brabrand S, Fosså SD, Cvancarova M, Axcrona U, Lehne G (2012) Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer. J Clin Oncol 30(32):4004–4010
Breunig C, Zengerling F, Schnöller T, Schrader M, Jentzmik F (2016) Aktuelle Therapie organbegrenzter Hodentumoren. (Recent therapy of organ-confined testis cancer). Aktuelle Urol 47(2):136–140
Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group III study group (2010) Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol 58:134–141
Capelouto CC, Clark PE, Ransil BJ, Loughlin KR (1995) A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? J Urol 153:981–985
Casteren NJ van, Boellaard WP, Dohle GR, Weber RF, Kuizinga MC, Stoop H, Oosterhuis WJ, Looijenga LH (2008) Heterogeneous distribution of ITGCNU in an adult testis: consequences for biopsy-based diagnosis. Int J Surg Pathol 16:21–24
Chapple A, McPherson A (2004) The decision to have a prosthesis: a qualitative study of men with testicular cancer. Psychooncology 13:654–664
Clifford TG, Burg ML, Hu B, Loh-Doyle J, Hugen CM, Cai J, Djaladat H, Wayne K, Daneshmand S (2018) Satisfaction with testicular prosthesis after radical orchiectomy. Urology 114:128–132
Colpi GM, Carmignani L, Nerva F, Guido P, Gadda F, Castiglioni F (2005) Testicular-sparing microsurgery for suspected testicular masses. BJU Int 96:67–69
Daneshmand S, Djaladat H, Porter CR, Nichols C (2011) Evaluation and preservation of fertility in patients with testicular cancer. J Adolesc Young Adult Oncol 1(1):25–29
Dieckmann KP (2007) Diagnostic delay in testicular cancer: an analytic chimaera or a worthy goal? Eur Urol 52:1566–1568
Dieckmann KP (2015) Contralateral biopsies in patients with testicular germ cell tumour – nuisance or new sense? Ann Oncol 26(4):620–621
Dieckmann KP, Loy V (1993) Seminoma testis after testis sparing excision of testicular teratoma. Br J Urol 71:612–613
Dieckmann KP, Loy V (2003) False-negative biopsies for the diagnosis of testicular intraepithelial neoplasia (TIN) – an update. Eur Urol 43:516–521
Dieckmann KP, Heinemann V, Frey U, Pichlmeier U (2005) How harmful is contralateral testicular biopsy?-An analysis of serial imaging studies and a prospective evaluation of surgical complications. Eur Urol 48:662–672
Dieckmann KP, Kulejewski M, Pichlmeier U, Loy V (2007) Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy. Eur Urol 51:175–185
Dieckmann KP, Kulejewski M, Heinemann V, Loy V (2011) Testicular biopsy for early cancer detection – objectives, technique and controversies. Int J Androl 34(4 Pt 2):e7–e13
Dieckmann KP, Frey U, Lock G (2013a) Contemporary diagnostic work up of testicular germ cell tumours. Nat Rev Urol 10(12):703–712
Dieckmann KP, Wilken S, Loy V, Matthies C, Kleinschmidt K, Bedke J, Martinschek A, Souchon R, Pichlmeier U, Kliesch S (2013b) Treatment of testicular intraepitelial neoplasia (intratubular germ cell neoplasia unspecified) with local radiotherapy or with platinum-based chemotherapy: a survey of the German Testicular Cancer Study Group. Ann Oncol 24(5):1332–1337
Dieckmann KP, Anheuser P, Schmidt S, Soyka-Hundt B, Pichlmeier U, Schriefer P, Matthies C, Hartmann M, Ruf CG (2015) Testicular prostheses in patients with testicular cancer – acceptance rate and patient satisfaction. BMC Urol 15(1):16
Djaladat H (2015) Organ-sparing surgery for testicular tumours. Curr Opin Urol 25(2):116–120
Elert A, Olbert P, Hegele A, Barth P, Hofmann R, Heidenreich A (2002) Accuracy of frozen section examination of testicular tumors of uncertain origin. Eur Urol 41(3):290–293
Fossa SD, Aass N, Heilo A, Daugaard G, Skakkebaek NE, Stenwig AE, Nesland JM, Looijenga LH, Oosterhuis JW (2003) Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy. Ann Oncol 14:1412–1418
Fossa SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB (2005) Risk of contralateral testicular cancer: a population-based study of 29.515 U.S. men. J Natl Cancer Inst 97:1056–1066
Geldart TR, Simmonds PD, Mead GM (2002) Orchidectomy after chemotherapy for patients with metastatic testicular germ cell cancer. BJU Int 90:451–455
Giannarini G, Dieckmann KP, Albers P, Heidenreich A, Pizzocaro G (2010) Organ-sparing surgery for adult testicular tumours: a systematic review of the literature. Eur Urol 57(5):780–790
Gilbert K, Nangia AK, Dupree JM, Smith JF, Mehta A (2018) Fertility preservation for men with testicular cancer: is sperm cryopreservation cost effective in the era of assisted reproductive technology? Urol Oncol 36(3):92.e1–92.e9
Glicksman R, Hamilton RJ, Chung P (2017) Retroperitoneal hematoma following radical orchiectomy: two cases. Can Urol Assoc J 11(1–2):E35–E37
Goldstein M, Waterhouse K (1983) When to use the Chevassu maneuver during exploration of intrascrotal masses. J Urol 130:1199–1200
Hamano I, Hatakeyama S, Ohyama C (2017) Fertility preservation of patients with testicular cancer. Reprod Med Biol 16(3):240–251
Hanna NH, Einhorn LH (2014) Testicular cancer – Discoveries and updates. N Engl J Med 371(21):2005–2016
Hartmann JT, Fossa SD, Nichols CR, Droz JP, Horwich A, Gerl A, Beyer J, Pont J, Fizazi K, Hecker H, Kanz L, Einhorn L, Bokemeyer C (2001) Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Natl Cancer Inst 93(22):1733–1738
Heidenreich A (2009) Contralateral testicular biopsy in testis cancer: current concepts and controversies. BJU Int 104(9 Pt B):1346–1350
Heidenreich A, Albers P (2019) Ablatio testis und Enukleationsresektion. Aktuelle Urol 50:106–112
Heidenreich A, Weissbach L, Höltl W, Albers P, Kliesch S, Köhrmann KU, Dieckmann KP (2001) Organ sparing surgery for malignant germ cell tumors of the testis. J Urol 166:2161–2165
Heidenreich A, Bokemeyer C, Souchon R (2009) Stadienspezifische Therapie testikulärer Keimzelltumoren. Urologe A 48(4):377–385
Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE (2003) Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 200:370–374
Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, Skakkebaek NE (2005) Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol 16:863–868
Huyghe E, Soulie M, Escourrou G, Mieusset R, Plante P, Thonneau P (2005) Conservative management of small testicular tumors relative to carcinoma in situ prevalence. J Urol 173:820–823
Huyghe E, Muller A, Mieusset R, Bujan L, Bachaud JM, Chevreau C, Plante P, Thonneau P (2007) Impact of diagnostic delay in testis cancer: results of a large population based study. Eur Urol 52:1710–1716
Khetpal R, Katz MD, Cox M, Arnaoutakis K (2014) The role of salvage hemiscrotectomy in testicular cancer after scrotal contamination: a case report and literature review. Clin Genitourin Cancer 12(3):e103–e106
Kier MG, Lauritsen J, Almstrup K, Mortensen MS, Toft BG, Rajpert-De Meyts E, Skakkebaek NE, Rørth M, von der Maase H, Agerbaek M, Holm NV, Andersen KK, Dalton SO, Johansen C, Daugaard G (2015) Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study (DaTeCa 03 study). Ann Oncol 26(4):737–742
Kirkham AP, Kumar P, Minhas S, Freeman AA, Ralph DJ, Muneer A, Allen C (2009) Targeted testicular excision biopsy: when and how should we try to avoid radical orchidectomy? Clin Radiol 64:1158–1165
Kliesch S (2003) Fertilität bei Patienten mit Hodenerkrankungen. Onkologe 9:955–961
Kliesch S (2004) Diagnostik und Primärtherapie des Hodentumors. Urologe A 43:1494–1499
Kliesch S, Thomaidis T, Schütte B, Puhse G, Kater B, Roth S, Bergmann M (2003) Update on the diagnostic safety for detection of testicular intraepithelial neoplasia (TIN). APMIS 111:70–74
Klosky JL, Wang F, Russell KM, Zhang H, Flynn JS, Huang L, Wasilewski-Masker K, Landier W, Leonard M, Albritton KH, Gupta AA, Casillas J, Colte P, Kutteh WH, Schover LR (2017) Prevalence and predictors of sperm banking in adolescents newly diagnosed with cancer: examination of adolescent, parent, and provider factors influencing fertility preservation outcomes. J Clin Oncol 35(34):3830–3836
Lambert SM, Fisch H (2007) Infertility and testis cancer. Urol Clin North Am 34:269–277
Leibovitch I, Baniel J, Foster RS, Donohue JP (1995) The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer. J Urol 154:935–939
Leroy X, Rigot JM, Aubert S, Ballereau C, Gosselin B (2003) Value of frozen section examination for the management of nonpalpable incidental testicular tumors. Eur Urol 44:458–460
Magelssen H, Haugen TB, von During V, Melve KK, Sandstad B, Fossa SD (2005) Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it? Eur Urol 48:779–785
Masterson TA, Cary C, Rice KR, Foster RS (2015) The evolution and technique of nerve-sparing retroperitoneal lymphadenectomy. Urol Clin North Am 42(3):311–320
Matei DV, Vartolomei MD, Renne G, Tringali VM, Russo A, Bianchi R, Cozzi G, Bottero D, Musi G, Mazzarol G, Ferro M, de Cobelli O (2017) Reliability of frozen section examination in a large cohort of testicular masses: what did we learn? Clin Genitourin Cancer 15(4):e689–e696
Mortensen MS, Gundgaard MG, Daugaard G (2011) Treatment options for carcinoma in situ testis. Int J Androl 34(4 pt 2):e32–e36
Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Shuch B, Sircar K, Somer B, Wilder RB, Dwyer M, Kumar R (2015) Testicular cancer, version 2.2015. J Natl Compr Cancer Netw 13(6):772–799
Moul JW (2007) Timely diagnosis of testicular cancer. Urol Clin North Am 34:109–117
Nikzas D, Champion AE, Fox M (1990) Germ cell tumours of testis: prognostic factors and results. Eur Urol 18(4):242–247
Oldenburg J (2015) Hypogonadism and fertility issues following primary treatment for testicular cancer. Urol Oncol 33(9):407–412
Ostrowski KA, Walsh TJ (2015) Infertility with testicular cancer. Urol Clin North Am 42(3):409–420
Öztürk Ç, Fleer J, Hoekstra HJ, Hoekstra-Weebers JE (2015) Delay in diagnosis of testicular cancer; a need for awareness programs. PLoS One 10(11):e0141244
Paffenholz P, Held L, Loosen SH, Pfister D, Heidenreich A (2018) Testis-sparing surgery for benign testicular masses – diagnostics and therapeutic approaches. J Urol 200(2):353–360
Ping P, Gu BH, Li P, Huang YR, Li Z (2014) Fertility outcome of patients with testicular tumor: before and after treatment. Asian J Androl 16(1):107–111
Pizzocaro G, Guarneri A (2009) Inguinal orchidectomy for testicular cancer. BJU Int 103:704–716
Prym C, Lauke H (1994) Carcinoma -in-situ of the human testis: tumour cells are distributed focally in the seminiferous tubules. Andrologia 26:231–234
Reekhaye A, Harris A, Nagarajan S, Chadwick D (2016) A giant testicular mixed germ cell tumour. Ann R Coll Surg Engl 98(8):e171–e172
Richie JP (1984) Simultaneous bilateral tumors with unorthodox management. World J Urol 2:74
Robinson R, Tait C, Clarke N, Ramani V (2016) Is it safe to insert a testicular prosthesis at the time of radical orchidectomy for testis cancer – an audit of 904 men undergoing radical orchidectomy. BJU Int 117:249–252
Rud CN, Daugaard G, Rajpert-De Meyts E, Skakkebæk NE, Petersen JH, Jørgensen N (2013) Sperm concentration, testicular volume and age predict risk of carcinoma-in-situ in contralateral testis of men with testicular germ-cell cancer. J Urol 190(6):2074–2080
Ruf CG, Gnoss A, Hartmann M, Matthies C, Anheuser P, Loy V, Pichlmeier U, Dieckmann KP (2015) Contralateral biopsies in patients with testicular germ cell tumours: patterns of care in Germany and recent data regarding prevalence and treatment of testicular intra-epithelial neoplasia. Andrology 3(1):92–98
Scholz M, Zehender M, Thalmann GN, Borner M, Thoni H, Studer UE (2002) Extragonadal retroperitoneal germ cell tumor: evidence of origin in the testis. Ann Oncol 13:121–124
Seppelt U (1982) Enukleation eines sukzessiven Zweittumors im Resthoden. Therapiewoche 32:560–563
Sibert L, Rives N, Rey D, MacE B, Grise P (1999) Semen cryopreservation after orchidectomy in men with testicular cancer. BJU Int 84:1038–1042
Sonnenburg DW, Brames MJ, Case-Eads S, Einhorn LH (2015) Utilization of sperm banking and barriers to its use in testicular cancer patients. Support Care Cancer 23(9):2763–2768
Taksey J, Bissada NK, Chaudhary UB (2003) Fertility after chemotherapy for testicular cancer. Arch Androl 49:389–395
Tandstad T, Solberg A, Håkansson U, Stahl O, Haugnes HS, Oldenburg J, Dahl O, Kjellman A, Angelsen A, Cohn-Cedermark GS (2014) Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. Acta Oncol 54(4):493–499
Ulbright TM (2008) The most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them. Adv Anat Pathol 15:18–27
Verrill C, Perry-Keene J, Srigley JR, Zhou M, Humphrey PA, Lopez-Beltran A, Egevad L, Ulbright TM, Tickoo SK, Epstein JI, Compérat E, Berney DM, Panel. MotITT (2018) Intraoperative consultation and macroscopic handling: The International Society of Urological Pathology (ISUP) testicular cancer consultation conference recommendations. Am J Surg Pathol 42(6):e33–e43
Watson RA, Morgan RD, Joseph J, Sivakumar S, Verrill C, Tuthill M, Sullivan M, Protheroe AS (2018) Bilateral testicular germ cell tumors: a case-series from a UK-based tertiary referral center over 19 years. Clin Genitourin Cancer 16(3):e513–e516
Wittekind C (2014) TNM-Klassifikation der Hodentumoren Definitionen und Voraussetzungen einer richtigen Anwendung. Pathologe 35(3):252–255
Wood L, Kollmannsberger C, Jewett M, Chung P, Hotte S, O’Malley M, Sweet J, Anson-Cartwright L, Winquist E, North S, Tyldesley S, Sturgeon J, Gospodarowicz M, Segal R, Cheng T, Venner P, Moore M, Albers P, Huddart R, Nichols C, Warde P (2010) Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J 4(2):e19–e38
Yossepowitch O, Aviv D, Wainchwaig L, Baniel J (2011) Testicular prostheses for testis cancer survivors: patient perspectives and predictors of long-term satisfaction. J Urol 186(6):2249–2252
Zuniga A, Lawrentschuk N, Jewett MA (2010) Organ-sparing approaches for testicular masses. Nat Rev Urol 7(8):454–464
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Dieckmann, KP., Heidenreich, A. (2019). Maligne Hodentumoren: Therapie des Primärtumors. In: Rübben, H., Hakenberg, O., Grimm, MO., Burger, M. (eds) Uroonkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54652-9_63-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-54652-9_63-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54652-9
Online ISBN: 978-3-662-54652-9
eBook Packages: Springer Referenz Medizin